Treatment Patterns by Race and Ethnicity in Newly Diagnosed Persons with Multiple Sclerosis.

ABSTRACT:

Background

Non-Hispanic Black and Hispanic persons with MS (pwMS) are more likely to experience rapid disease progression and severe disability than non-Hispanic White pwMS; however, it is unknown how the initiation of high-efficacy disease-modifying therapies (DMTs) differs by race/ethnicity. This real-world study describes DMT treatment patterns in newly diagnosed pwMS in the United States (US) overall and by race/ethnicity.

Methods

This retrospective analysis used the US Optum Market Clarity claims/electronic health records database (January 2015-September 2020). pwMS who were first diagnosed in 2016 or later and initiated any DMT in the two years following diagnosis were included. Continuous enrollment in the claims data for ≥ 12 months before and ≥ 24 months after diagn

SUBMITTER: Geiger CK 

PROVIDER: S-EPMC10730787 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature